Search This Blog

Sunday, January 9, 2022

Idorsia's insomnia drug gets U.S. FDA approval

 Swiss drugmaker Idorsia said on Monday it has received the U.S. Food and Drug Administration's approval for its treatment for insomnia in adult patients.

https://www.marketscreener.com/quote/stock/IDORSIA-LTD-35837944/news/Idorsia-s-insomnia-drug-gets-U-S-FDA-approval-37503413/

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.